An act relating to prescriptions for psychotropic medications used by children and youth in the Dr. Dynasaur program

H 522 would require enhanced oversight, informed consent processes, and accountability measures for prescriptions of psychotropic medications (medications affecting mood or behavior) for children and youth enrolled in Vermont's Dr. Dynasaur program. The bill mandates that healthcare providers obtain specific, documented informed consent from parents or guardians before prescribing these medications and establishes clearer reporting requirements for providers. It directly affects children and youth in the Dr. Dynasaur program and the healthcare providers who prescribe these medications within it. The bill aims to strengthen safeguards around the use of such medications for vulnerable young people.